MARKET WIRE NEWS

CERo Therapeutics Holdings Inc. Warrants (NASDAQ : CEROW ) Stock

Share:

MWN-AI** Summary

MWN-AI** Analysis

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.


Description


CERo Therapeutics Holdings, Inc. is an immunotherapy company advancing the development of engineered T cell therapeutics for the treatment of cancer. The Company¿s proprietary approach to T cell engineering, enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, which is designed to engage the body¿s full immune repertoire to achieve optimized cancer therapy. Its cellular immunotherapy platform is focused on redirecting patient-derived T cells to eliminate tumors by building in engulfment pathways that employ phagocytic mechanisms to destroy cancer cells, creating CERo, which is referred to as chimeric engulfment receptor t cells (CER-T). The Company is initiating clinical trials for its lead product candidate, CER-1236, for hematological malignancies.


Quote


Last:$0.0044
Change Percent: -76.84%
Open:$0.007
Close:$0.019
High:$0.0078
Low:$0.0037
Volume:1,000,642
Last Trade Date Time:10/30/2025 12:44:39 pm

Stock Data


Market Cap:$1,419,782
Float:19,556,591
Insiders Ownership:N/A
Institutions:30
Short Percent:N/A
Industry:Biotechnology & Life Sciences
Sector:Healthcare
Website:www.cero.bio
Country:US
City:South San Francisco

Recent News Releases


Subscribe to Our Newsletter


Message Board Posts


**MWN-AI FAQ is based on asking OpenAI questions about CERo Therapeutics Holdings Inc. Warrants (NASDAQ: CEROW).

Link Market Wire News to Your X Account

Download The Market Wire News App